| ROCKET PHARMACEUTICALS |
| USA |
| Gesundheit |
| US77313F1066 / A2JA9Q |
| 9IP1 (Frankfurt) / RCKT (NASDAQ) |
| FRA:9IP1, ETR:9IP1, 9IP1:GR, NASDAQ:RCKT |
| - |
| https://www.rocketpharma... |
|
Rocket Pharmaceuticals Inc. is a biotechnology com..
>Volltext.. |
| 360.92 Mio. EUR |
| 192.09 Mio. EUR |
| - |
| -202.89 Mio. EUR |
| -207.07 Mio. EUR |
| -1.93 EUR |
| 21.53 Mio. EUR |
| 65.28 Mio. EUR |
| -173.77 Mio. EUR |
| 7.15 |
| - |
| 11.43% |
| - |
| - |
| - |
| ROCKET PHARMACEUTICALS, ROCKET PHARMA, ROCKET PHARMACEUTICAL |
| 10.01.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|